TWC
GLMD icon

TD Waterhouse Canada’s Galmed Pharmaceuticals GLMD Stock Holding History

TD Waterhouse Canada’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Hold
0
– -$3 – 2095
2025
Q3 		– Hold
0
– – – 2060
2025
Q2 		– Hold
0
– – – 1985
2023
Q1 		– Sell
-1
Closed -$972 – 1773
2022
Q4 		$972 Hold
1
– – ﹤0.01% 1563
2022
Q3 		$423 Hold
1
– – ﹤0.01% 1638
2022
Q2 		$774 Hold
1
– – ﹤0.01% 1637
2022
Q1 		$2.03K Hold
1
– – ﹤0.01% 1594
2021
Q4 		$2.58K Buy
+1
New +$3.61K ﹤0.01% 1556

Other funds holding GLMD

Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TD Waterhouse Canada's GLMD Position: Q4 2025 in Review

TD Waterhouse Canada held its Galmed Pharmaceuticals (GLMD) position steady in Q4 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

TD Waterhouse Canada first reported a position in GLMD in Q4 2021 and has held it in 5 quarters since. The position peaked at $2.58K in Q4 2021. 14 funds tracked by Wall St. Rank hold GLMD as of Q4 2025.

  • TD Waterhouse Canada held 0 shares of Galmed Pharmaceuticals worth $0 as of Q4 2025.
  • TD Waterhouse Canada left its Galmed Pharmaceuticals share count unchanged in Q4 2025.
  • Galmed Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q4 2025, its #2095 holding.
  • TD Waterhouse Canada first reported a position in Galmed Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
  • TD Waterhouse Canada's Galmed Pharmaceuticals position peaked at $2.58K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.